If you have reference to testing methods that are better now, please list them instead of putting up terrible analogies.
By the way Jon passed 10 tests PRIOR to his competition, including during weight cut, but then failed the test post fight after he was fully hydrated. Literally all you post is nonsense. You keep going off about common sense, but honestly you sound like a complete idiot.
"By the way," fuck off, you are wrong, as ususal. Don't you ever get tired of not having the basic facts correct? -
Although Jon Jones passed a post-fight blood screening post-UFC 214 on July 29th, he failed a urine test that was administered on July 28th before the fight. It is to be noted that, blood tests by USADA do not test for Turinabol, but the urine tests do. Jones was flagged for the same substances and hence he passed the post-fight drug test but was unable to pass the urine test before the fight.
July 28 = weight cut day, for the terminally dense.
https://www.essentiallysports.com/ufc-the-story-of-the-jon-jones-steroid-controversy/
And, obviously, for the second result, it was before the fight, since they changed the venue from Las Vegas to California and had the fight.
Okay, the analogies aren't terrible, because they fit your stupidity perfectly. And since I'm digging up scientific journals and translating them for you, you can fuck off, again, now that I've offered the verification of your ignorance on this.
So, - please list a reference to testing methods being better now than a decade ago - which is an inherently obtuse position to stake out, but here it is
Background reference, from the National Institutes of Health. This is the paper you have been referring to
NIH said:
Abstract
The biotransformation of dehydrochloromethyltestosterone (DHCMT, {DHCMT=Turinabol.... my notation, not NIH} 4-chloro-17β-hydroxy,17α-methylandrosta-1,4-dien-3-one) in man was studied with the aim to discover long-term metabolites valuable for the antidoping analysis. Having applied a high performance liquid chromatography for the fractionation of urinary extract obtained from the pool of several DHCMT positive urines, about 50 metabolites were found. Most of these metabolites were included in the GC-MS/MS screening method, which was subsequently applied to analyze the post-administration and routine doping control samples. As a result of this study, 6 new long-term metabolites were identified tentatively characterized using GC-MS and GC-MS/MS as 4-chloro-17α-methyl-5β-androstan-3α,16,17β-triol (M1), 4-chloro-18-nor-17β-hydroxymethyl,17α-methyl-5β-androsta-1,13-dien-3α-ol (M2), 4-chloro-18-nor-17β-hydroxymethyl,17α-methyl-5β-androst-13-en-3α-ol (M3), its epimer 4-chloro-18-nor-17α-hydroxymethyl,17β-methyl-5β-androst-13-en-3α-ol, 4-chloro-18-nor-17β-hydroxymethyl,17α-methylandrosta-4,13-dien-3α-ol (M4) and its epimer 4-chloro-18-nor-17α-hydroxymethyl,17β-methylandrosta-4,13-dien-3α-ol. The most long-term metabolite M3 was shown to be superior in the majority of cases to the other known DHCMT metabolites, such as 4-chloro-18-nor-17β-hydroxymethyl,17α-methylandrosta-1,4,13-trien-3-one and 4-chloro-3α,6β,17β-trihydroxy-17α-methyl-5β-androst-1-en-16-one.
We've identified the terminology for Turniabol, and the M3 metabolite, first identified in this paper, in 2011.
A 2015 paper published on using a newer technique to test for DHCMT -
Agillent_Systems said:
Abstract
Oral-Turinabol, dehydrochloromethyltestosterone (DHCMT), is a synthetic anabolic androgenic steroid (AAS) prohibited in sports by the World Anti-Doping Agency. We used accurate-mass measurements by liquid chromatography coupled to a quadrupole time-of-flight (LC/MS Q-TOF) system to investigate DHCMT metabolites.....
...... According to our bibliographic search, no previous studies on the detection of Oral-Turinabol consumption by liquid chromatography-mass spectrometry have been reported...
.... Gas chromatography-mass spectrometry (GC/MS) is the common method of choice for the detection of Oral-Turinabol administration.
So, new methods of testing for the metabolites, in 2015, which would be AFTER 2011.
https://www.agilent.com/cs/library/applications/5991-6019EN.pdf
Here's a state of the science symposium called "RECENT ADVANCES IN DOPING ANALYSIS", April 2018, which is less than a year after Jones got popped, which would qualify as "recent."
Page 29
We presented results at the 2015 MDI Workshop demonstrating the improved capacity of the Agilent 7010 high efficience sources (HES) to detect at levels previously unatainable by the 7000 series systems
NOTE: same systems manufacturer as in the paper, above, previous demonstration of IMPROVED CAPACITY dated the same time as the above paper. However, it is a different technology than in the paper, so, from the same company, we now count at least TWO technological advancements.
Typical GC/MS source designs introduce and electron beam perpendicular to the resulting ion beam......
..... a few years ago, a new high efficiency source (HES) model was introduced by Agilent (7010 source design) which orients the electron beam to be coaxial to the ion beam, minimizing the loss of ion density within the source. These sources were tested for both qualitative and quantitaive analysis in urinary matrices. Results are discussed here.
So, we have the "common method of choice" that is used for DHCMT, being discussed here, with improvements to that method. AS YOU REQUESTED.
A new GC-MS/MS7010 system was installed for system suitability testing at the Montreal Anti-Doping lab in August 2015.....
... Figure 1 compares signals generated in the acquisition window of DHCMT long term metabolite (4-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5a-androst-13-en-3α-ol) for 2 samples injected first on a 7000C system and a second on a 7010 system. On the 7000C system, the two samples generated small signals that were not clearly distinguishable from baseline noise...
TRANSLATION: In testing the two samples against a baseline/control of infant urine sample, the pre-2015 system did not detect the M3 metabolite in either sample tested, and the two samples one which had very low concentrations of M3 and one which did not, showed up the same in the tests.
... but reanalysis on an HES system clearly establishes the presence of the DHCMT metabolite in sample 2, and its absence from sample 1. Thanks to these new sources, the laboratory has been able to report a number of AAFs at concentrations reaching as low as 10pg/ml, levels previously unachievable by the 7000 series systems.
..... the increased specificity of the 7010 sources allow a clear differntiation from a low concentration positive sample (<50 pg/ml) from a negative sample.
https://www.dshs-koeln.de/fileadmin...ecent_Advances_in_Doping_Analysis_26_2018.pdf
So, yeah, biochemical analytical technology has improved with the passage of years, just like it has for every kind of advanced technology out there. That you demanded proof of this is absurd, but there it is, specifically as it applies to the M3 metabolite for Turinabol.
So, again, fuck off. I'm done with you and your stupidity, and I'm not doing any more research to prove what should be obvious to anyone with a functioning brain.